A Clinical Follow-up Study on the Efficacy of Thumbtack Needle for Postoperative Sleep and Recovery Treatment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-55
SponsorThe First Affiliated Hospital of Xiamen University

About this trial

To understand the impact of thumb-tack needle therapy on postoperative sleep and recovery in patients who have undergone general anesthesia, and to explore the clinical significance of thumb-tack needle therapy in improving postoperative sleep quality, preventing postoperative sleep disorders, and promoting postoperative recovery

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients undergoing breast cancer surgery with general anesthesia in the hospital;

American Society of Anesthesiologists (ASA) classification I-II;

Women aged 18-55 years;

No history of chronic insomnia;

Disqualifiers

Those who do not meet the aforementioned inclusion criteria;

A history of severe heart, brain, lung, or kidney diseases (such as acute coronary syndrome (ACS), severe heart failure classified as NYHA Class III or IV, severe arrhythmias, severe valvular disease; acute aortic disease, and severe peripheral vascular disease, etc.), or poor physical condition (including reduced exercise tolerance, multi-organ dysfunction, malnutrition, etc.);

A history of sleep disorders and psychiatric history;

Inability to receive thumb-tack needle treatment.

Trial population

Patients undergoing breast cancer surgery with general anesthesia in the hospital

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

Not listed

Trial groups

110 Participants
are grouped into 1 trial group
Group A: Patients undergoing breast cancer surgery with general anesthesia in the hospital

Trial outcomes

Primary outcomes

1

Pittsburgh sleep quality index(PSQI)

Total scores range from 0 to 21, with higher scores indicating worse sleep quality.

Time frame
1 day or 2 days before anesthesia exposure and 1, 3, and 7 days after anesthesia exposure.

Secondary outcomes

1

Later Recovery evaluated by QoR-40 questionnaire

The maximum total score is 200, with higher scores indicating better recovery quality

Time frame
QoR-40 score on the third day after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The First Affiliated Hospital of Xiamen University

Lead sponsor

Fujian Medical University

Sponsor institution